This is not a paywall.

Register for free to continue reading.

The news sucks. But your reading experience doesn't have to. Help us improve that for you by registering for free.

Please create a password or click to receive a login link.

Please enter your password or get a login link if you’ve forgotten

Open Sesame! Thanks for registering.

First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

A South African Hero: You

There’s a 99.7% chance that this isn’t for you. Only 0.3% of our readers have responded to this call for action.

Those 0.3% of our readers are our hidden heroes, who are fuelling our work and impacting the lives of every South African in doing so. They’re the people who contribute to keep Daily Maverick free for all, including you.

We need so many more of our readers to join them. The equation is quite simple: the more members we have, the more reporting and investigations we can do, and the greater the impact on the country. We are inundated with tip-offs; we know where to look and what to do with the information when we have it – we just need the means to help us keep doing this work.

Be part of that 0.3%. Be a Maverick. Be a Maverick Insider.

Support Daily Maverick→
Payment options

Medscheme’s legal battle with software developer coul...

Business Maverick


Medscheme’s legal battle with software developer could end up costing about R750m

Medscheme and software developer company Neil Harvey and Associates are embroiled in a prolonged legal case that could see the medical aid administrator paying about R750-million if it loses the case next year.

First published in the Daily Maverick 168 weekly newspaper.

A 15-year-old legal battle between medical aid administrator Medscheme, which is owned by the listed healthcare company AfroCentric and Sanlam, and software developer Neil Harvey and Associates (NHA) is reaching its climax. Does AfroCentric have a big legal problem? The short answer is “maybe”.

AfroCentric has consistently suggested in communications with shareholders that its dispute with NHA was an inconsequential case it would easily win. But recent events have made it clear there may be more to the case than AfroCentric has disclosed to shareholders.

It is a remarkable case, in many ways, because both sides chose arbitration rather than going to court proper since this was supposed to be the quickest and least expensive route to achieve a resolution; but now it’s 15 years later and the legal bills alone amount to sums running into hundreds of millions of rands.

Technically, the claim is for R375-million, but should Medscheme lose, it could easily cost the company something in the region of R750-million with interest and legal expenses.

Both sides claim the other has been trying to delay the case, and both sides remain adamant that they will win when the case gets heard early next year. One important thing that has changed, however, is that NHA has won an aspect of the case, which does suggest AfroCentric shareholders should sit up and take notice.

Despite mountains of legal documents and issues, the dispute between the parties is fairly simple. In May 2003, Medscheme was in big trouble, and the number of medical aid members it administered had fallen from about one million to 600,000 principal members. The company recorded a R100-million loss that year.

As a result, Medscheme hired a new CEO, who hired NHA to replace its dysfunctional software system. NHA was established in the industry and had been operating since 1986.

Here things get a bit fuzzy. Medscheme decided to allocate four of the 20-odd schemes it was operating to NHA to fix – the four most difficult clients. Hence the schemes of Liberty, Sasol, Fedhealth and Omnihealth were moved over to NHA’s Medware system, which later incorporated its broker interface, called Electronic Membership Interface (EMI).

NHA claims this was all done on the explicit basis that, if these succeeded, Medscheme would award all or most of its clients to NHA. A contract was signed to this effect, although, like everything, there is a dispute about what exactly was undertaken. Medscheme says the wording is plainly in its favour; NHA says the wording generally expresses the intention, which was to award NHA more business should it succeed with the clients it was given, which it did.

But behind the scenes it was understandably panic stations from the existing software suppliers, who needed to up their game pronto.

The problem, according to NHA, is that they did so using NHA’s systems and know-how – and at least in this instance, by physically “stealing” the computer code. By agreement, the parties decided that this part of the case should be decided separately, and retired Judge Fritz Brand found broadly against Medscheme earlier this year.

Medscheme’s lawyer Roger Wakefield, a partner at Werksmans Attorneys, says the claim of “theft” is incorrect, because there was no criminal intention to steal something in the dead of night, and the finding was not one of theft. But what cannot be disputed is that the company illegally used NHA’s computer code, which formed part of the EMI. In his judgment, Brand said one of Medscheme’s employees had acted “dishonestly” and found Medscheme had infringed the copyright of NHA.

But it was only a partial victory for NHA because Brand awarded NHA R2.7-million, which was nothing close to the R21-million it had claimed, excluding interest. The result of the lower award is that, on top of everything else, the parties are disputing whether this was in fact a “victory” for NHA.

Wakefield said the outcome was “a big strategic win” for his client, because the damages award imposed was comparatively small, and because the judge did not agree with NHA on the co-responsibility of some defendants. This was the strongest aspect of their case, and NHA was awarded only a fraction of what it had claimed. The arbitrator also said the NHA had run the case “luxuriously”, Wakefield said.  

Neil Harvey says: “I am not sure how losing a case is a strategic win for anyone.” AfroCentric has raised several different defences over the years, which caused the EMI arbitration to be delayed twice, and in the end the judge found against them. Having won this aspect of the case, Harvey is confident about winning the main case.

But the problem here is that the main case revolves around the work and income that NHA claims it did not get as a result of the way their interaction unfolded.

This is a more complicated issue than a case of physically copying some computer code.

Wakefield says one of the issues is something called “emulation of functionality”, even though Medscheme is denying emulating any functionality. It is not illegal, in general, to make your software do the same thing as an existing system.

Harvey, however, claims this is not an “emulation of functionality” situation. The case, he says, is essentially about the misappropriation of confidential information and the resulting breach of contract.

The case will be heard in the first half of next year. DM168

This story first appeared in our weekly Daily Maverick 168 newspaper which is available for R25 at Pick n Pay, Exclusive Books and airport bookstores. For your nearest stockist, please click here.


Comments - share your knowledge and experience

Please note you must be a Maverick Insider to comment. Sign up here or sign in if you are already an Insider.

Everybody has an opinion but not everyone has the knowledge and the experience to contribute meaningfully to a discussion. That’s what we want from our members. Help us learn with your expertise and insights on articles that we publish. We encourage different, respectful viewpoints to further our understanding of the world. View our comments policy here.

No Comments, yet

Please peer review 3 community comments before your comment can be posted